Holdings
Johnson & Johnson
As of Jun 30, 2026, Johnson & Johnson reported 14 positions worth US$775M. Largest: Protagonist Therapeutics, Inc., Nanobiotix Sa and Meiragtx Holdings Plc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Protagonist Therapeutics, Inc. | 2.45M | US$300M | no change | Jun 30, 2026 |
| Nanobiotix Sa | 5.62M | US$212M | no change | Jun 30, 2026 |
| Meiragtx Holdings Plc | 6.64M | US$89.7M | no change | Jun 30, 2026 |
| Rapport Therapeutics, Inc. | 1.78M | US$74.4M | no change | Jun 30, 2026 |
| Contineum Therapeutics, Inc. | 1.98M | US$32.4M | no change | Jun 30, 2026 |
| Cvrx, Inc. | 4.02M | US$20.7M | no change | Jun 30, 2026 |
| Xencor, Inc. | 748K | US$12M | no change | Jun 30, 2026 |
| Cerebras Systems Inc. | 53,586 | US$11.8M | new | Jun 30, 2026 |
| Fate Therapeutics, Inc. | 3.38M | US$9.12M | no change | Jun 30, 2026 |
| Procept Biorobotics Corporation | 358K | US$8.08M | no change | Jun 30, 2026 |